However, in comparison to these three groups, tumor growth was significantly reduced in mice treated with the combination of anti-PD1 and anti-Bv8 antibodies, suggesting a sensitization of the tumor to anti-PD1 therapy. This evidence concerns the gene PROK2 and neoplasm.